Craft

Myomo

Stock Price

$3.9

2024-10-29

Market Capitalization

$119.4 M

2024-10-29

Revenue

$40.9 M

FY, 2025

Myomo Summary

Company Summary

Overview
Myomo is a medical myoelectric company that offers expanded mobility for those suffering from neurological disorders and upper-limb paralysis. It develops MyoPro, an electronically controlled brace used for regaining function in arms and hands paralyzed by a stroke, brachial plexus injury, cerebral palsy, or other neuromuscular disease or injury.
Type
Public
Status
Active
Founded
2004
HQ
Burlington, MA, US | view all locations
Website
https://myomo.com
Cybersecurity rating
Sectors

Key People

  • Paul R. Gudonis

    Paul R. Gudonis, Chairman & Chief Executive Officer

  • Thomas Kirk, Lead Independent Director, Chair of Nominating and Governance Committee

    • David Henry

      David Henry, Chief Financial Officer

    • Harry Kovelman

      Harry Kovelman, Chief Medical Officer

    LocationsView all

    1 location detected

    • Burlington, MA HQ

      United States

      45 Network Dr #101

    Myomo Financials

    Summary Financials

    Revenue (Q1, 2026)
    $10.1M
    Gross profit (Q1, 2026)
    $6.9M
    Net income (Q1, 2026)
    ($3.0M)
    Cash (Q1, 2026)
    $11.4M
    EBIT (Q1, 2026)
    ($3.2M)
    Enterprise value
    $129.7M

    Footer menu